Adjuvant targeted therapy is revolutionizing melanoma treatment, but also poses new challenges: Which patients should receive which drug, and to what end?
The British Journal of Dermatology
Original Article: Tackling Melanoma by Adjuvant Therapy: Why, Whom and How?